Femoral head infarction: a case-control study of a rare complication

股骨头梗死:一种罕见并发症的病例对照研究

阅读:1

Abstract

BACKGROUND: To determine the prevalence of the femoral head infarction (FHI) following hip arthroscopy, explore potential contributing factors, and assess its influence on clinical outcomes. METHODS: We evaluated consecutive patients who underwent hip arthroscopy in our hospital between May 2014 and May 2023 retrospectively. Patients underwent MRI at least one year after surgery. FHI was identified as large scale edema signal at the junction of the femoral head and neck in postoperative MRI. FHI were matched in a 1:3 cohort to the normal group based on sex, age, and body mass index (BMI). Preoperative patient-reported outcomes (PROs) and PROs at least one year after surgery were obtained. RESULTS: A total of 372 patients were finally included in this study. In the MRI follow-up, it was discovered that ten patients (2.7%) had FHI. Patients in FHI group had significantly lower BMI than patients without FHI (P = 0.008). Patients in the FHI group did not show significant improvements in postoperative mHHS, iHOT-12, or VAS scores (P > 0.05). Patients in the FHI group demonstrated significantly lower postoperative mHHS and iHOT-12 scores, along with higher VAS scores (P < 0.05). In the FHI group, only 3 patients (30%) surpassed the MCID and achieved the PASS for mHHS, while no patients surpassed the MCID or achieved the PASS for iHOT-12. The proportion of patients who achieved the MCID or the PASS in the normal group was significantly higher than that in the FHI group (P < 0.05). CONCLUSION: Our study demonstrated that FHI could be a rare complication following hip arthroscopy. Patients with lower BMI are at a higher risk of developing postoperative FHI. The clinical outcomes for patients with FHI are poor, with no significant improvement in patient-reported outcomes observed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。